Literature DB >> 8194617

High dosages of gonadotropins are associated with poor pregnancy outcomes after in vitro fertilization-embryo transfer.

L Stadtmauer1, E C Ditkoff, D Session, A Kelly.   

Abstract

OBJECTIVE: To compare the pregnancy outcomes during IVF-ET when different dosages of hMG are used after follicular phase suppression with leuprolide acetate (LA).
DESIGN: Retrospective chart review.
SETTING: Hospital-based IVF-ET program. PATIENTS: From January 1990 to December 1992, 264 cycles reached ET after LA downregulation and gonadotropin stimulation.
RESULTS: Higher doses of gonadotropins, as measured by both average daily dose and total dose per cycle, were associated with lower clinical pregnancy rates. This effect was independent of age, basal FSH level, endometrial thickness, maximal E2 levels, number of eggs retrieved, and embryos transferred.
CONCLUSION: High dosages of exogenous gonadotropins are associated with lower pregnancy rates in IVF-ET.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8194617     DOI: 10.1016/s0015-0282(16)56756-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  Mild IVF using GnRH agonist long protocol is possible: comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose.

Authors:  Sylvia Fernández-Shaw; Nuria Pérez Esturo; Rosa Cercas Duque; Isabel Pons Mallol
Journal:  J Assist Reprod Genet       Date:  2009-01-17       Impact factor: 3.412

2.  Zygote versus embryo transfer: a prospective randomized multicenter trial.

Authors:  Brian Dale; Agnese Fiorentino; Maria Laura de Simone; Loredana di Matteo; Antonio Scotto di Frega; Martin Wilding; Peter Fehr; Emma Bassan; Cristoforo Lo Giudice; Antonio Maselli; Fulvio Cappiello; Fulvio Zullo
Journal:  J Assist Reprod Genet       Date:  2002-10       Impact factor: 3.412

3.  Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles.

Authors:  Valerie L Baker; Morton B Brown; Barbara Luke; George W Smith; James J Ireland
Journal:  Fertil Steril       Date:  2015-08-18       Impact factor: 7.329

Review 4.  The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?

Authors:  M H van Hooff
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

5.  Are poor responders patients at higher risk for producing aneuploid embryos in vitro?

Authors:  Amanda Souza Setti; Daniela Paes de Almeida Ferreira Braga; Rita de Cássia Savio Figueira; Matheus de Castro Azevedo; Assumpto Iaconelli; Edson Borges
Journal:  J Assist Reprod Genet       Date:  2010-11-26       Impact factor: 3.412

Review 6.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

7.  The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome.

Authors:  D L Hock; H Louie; R M Shelden; C V Ananth; E Kemmann
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

8.  FSH dose is negatively correlated with number of oocytes retrieved: analysis of a data set with ~650,000 ART cycles that previously identified an inverse relationship between FSH dose and live birth rate.

Authors:  Zaramasina L Clark; Mili Thakur; Richard E Leach; James J Ireland
Journal:  J Assist Reprod Genet       Date:  2021-04-08       Impact factor: 3.357

9.  FSH dose to stimulate different patient' ages: when less is more.

Authors:  Edson Borges; Bianca F Zanetti; Amanda S Setti; Daniela Paf Braga; Rita de Cássia S Figueira; Assumpto Iaconelli
Journal:  JBRA Assist Reprod       Date:  2017-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.